NEW YORK (GenomeWeb News) – BioFocus and Almac today announced a deal to provide compound screening and profiling services based on Almac's Flexyte fluorescence lifetime assays to BioFocus' customers.
BioFocus has launched an FLT screening and profiling service using the Flexyte assay platform and is offering services against targets such as proteases, phosphatases, and kinases.